Arquivamento - Art. 36 §1° da LPI
#11.2
01/10/2023
RPI 2714
Application data
Number
112019010275Type
Filing
Publication
PCT
IB2017057759 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 01/10/2023. We update with every new RPI gazette, published weekly.
Applicants
GLAXOSMITHKLINE BIOLOGICALS S.A.
BE
Inventors
A. V. (pessoa física)
IT
B. W. (pessoa física)
US
S. C. (pessoa física)
IT
V. A. (pessoa física)
IT
IPC Classification
Priority claims
US
62/432,033 · 12/09/2016
US
62/465,378 · 03/01/2017
Abstract
A invenção provê vetores adenovirais compreendendo os transgenes que codificam os antígenos Lyssavirais. Os vetores podem ser usados para produzir vacinas para a profilaxia, melhora e tratamento de doenças causadas por doenças Lyssavirais, por exemplo, raiva.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
01/10/2023
RPI 2714
#6.23
10/04/2022
RPI 2700
#15.35
10/05/2021
RPI 2648
#1.3
09/17/2019
RPI 2541
#1.1
05/28/2019
RPI 2525
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.